CA2083333A1 - Compositions a usage topique a forte dose de collagenase - Google Patents

Compositions a usage topique a forte dose de collagenase

Info

Publication number
CA2083333A1
CA2083333A1 CA2083333A CA2083333A CA2083333A1 CA 2083333 A1 CA2083333 A1 CA 2083333A1 CA 2083333 A CA2083333 A CA 2083333A CA 2083333 A CA2083333 A CA 2083333A CA 2083333 A1 CA2083333 A1 CA 2083333A1
Authority
CA
Canada
Prior art keywords
collagenase
high dosage
topical forms
dosage topical
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2083333A
Other languages
English (en)
Other versions
CA2083333C (fr
Inventor
Harold Stern
David Yee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance Biofactures of Curacao NV
Original Assignee
Harold Stern
David Yee
Advance Biofactures Of Curacao, N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harold Stern, David Yee, Advance Biofactures Of Curacao, N.V. filed Critical Harold Stern
Publication of CA2083333A1 publication Critical patent/CA2083333A1/fr
Application granted granted Critical
Publication of CA2083333C publication Critical patent/CA2083333C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
CA002083333A 1991-11-20 1992-11-19 Compositions a usage topique a forte dose de collagenase Expired - Fee Related CA2083333C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US79591591A 1991-11-20 1991-11-20
US07/795,915 1991-11-20
US07/963,995 US5393792A (en) 1991-11-20 1992-10-29 High dosage topical forms of collagenase
US07/963,995 1992-10-29

Publications (2)

Publication Number Publication Date
CA2083333A1 true CA2083333A1 (fr) 1993-05-21
CA2083333C CA2083333C (fr) 2000-05-30

Family

ID=27121667

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002083333A Expired - Fee Related CA2083333C (fr) 1991-11-20 1992-11-19 Compositions a usage topique a forte dose de collagenase

Country Status (12)

Country Link
US (3) US5393792A (fr)
EP (1) EP0543521B1 (fr)
JP (1) JPH0789871A (fr)
AT (1) ATE179612T1 (fr)
AU (1) AU654881B2 (fr)
CA (1) CA2083333C (fr)
DE (1) DE69229098T2 (fr)
ES (1) ES2130162T3 (fr)
HU (1) HUT62802A (fr)
RU (1) RU2129862C1 (fr)
SI (1) SI9200334A (fr)
YU (1) YU98792A (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE213955T1 (de) * 1994-12-15 2002-03-15 Advance Biofactures Curacao Verminderung des fettgewebes durch verwendung von kollagenase
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
DE19503338C2 (de) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung und ihre Verwendung
US5718897A (en) * 1995-06-07 1998-02-17 Trustees Of Tufts College Enhancing keratinocyte migration and proliferation
US5851522A (en) * 1995-06-07 1998-12-22 Trustees Of Tufts College Enhancing keratinocyte migration
DE19521829A1 (de) * 1995-06-16 1996-12-19 Knoll Ag Neue Verwendung von Collagenase
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
AU3954199A (en) * 1998-06-03 1999-12-20 Hwa Seong Kim Adhesion / fixation / cooling remedies for burn and therapeutic method for relieving burn scar
DE19825794A1 (de) * 1998-06-10 1999-12-16 Knoll Ag Collagenase-Applikationsform
IL127209A0 (en) * 1998-11-23 1999-09-22 Bio Silk Ltd Composition and method for treatment of hypertrophic skin accumulations and their prevention
US20030198631A1 (en) * 2002-04-18 2003-10-23 Healthpoint, Ltd. Thermolysin enzymatic wound debrider
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
EP1773379A4 (fr) * 2004-07-13 2009-07-15 Mediwound Ltd Compositions et methodes de cicatrisation pour lesions dermatologiques
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
ITPD20050207A1 (it) * 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
CN1935262B (zh) * 2005-09-23 2010-12-29 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备抗人乳头瘤病毒药物的用途
US20070141106A1 (en) * 2005-10-19 2007-06-21 Bonutti Peter M Drug eluting implant
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US8642059B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
WO2010050980A1 (fr) * 2008-10-31 2010-05-06 Laboratory Skin Care, Inc. Formulations topiques comprenant des particules d'hydroxyapatite pour la stimulation et le maintien des fibres de collagène
AU2010328269B2 (en) 2009-12-08 2014-07-10 Smith & Nephew Orthopaedics Ag Enzymatic wound debriding compositions with enhanced enzymatic activity
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
ES2740499T3 (es) 2012-01-12 2020-02-05 Endo Global Ventures Enzima de Clostridium histolyticum
US10537293B2 (en) * 2012-02-21 2020-01-21 Canon Medical Systems Corporation X-ray CT system, image display device, and image display method
US9636385B2 (en) 2012-10-24 2017-05-02 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US11382958B2 (en) 2016-01-31 2022-07-12 Mediwound Ltd. Debriding composition for treating wounds
WO2017183018A1 (fr) 2016-04-18 2017-10-26 Mediwound Ltd Procédés de débridement de plaies chroniques
CN115969318A (zh) 2017-03-01 2023-04-18 恩多风投有限公司 用于评估和治疗橘皮组织的装置和方法
MX2019011574A (es) 2017-03-28 2019-12-19 Endo Ventures Ltd Método mejorado para producir aplicaciones relacionadas con la colagenasa.
US20220362327A1 (en) * 2021-05-13 2022-11-17 Nasser Diab Compositions and methods for wound healing

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH437641A (de) * 1961-05-30 1967-06-15 Bernburg Serum Werk Veb Verfahren zur Herstellung von fettfreien Salbengrundlagen
US3392161A (en) * 1964-10-15 1968-07-09 Gen Tire & Rubber Co Gel-free halogenated polybutadiene rubber-resins
US3705083A (en) * 1966-07-08 1972-12-05 Agricultural Biolog Corp Process for producing collagenase
US3792161A (en) * 1970-05-18 1974-02-12 Research Corp Burn ointment comprising silver sulfadiazine and collagenase
US3678158A (en) * 1971-05-11 1972-07-18 Worthington Bio Chem Corp Treatment of herniated intervertebral discs of mammals
US4089333A (en) * 1972-10-28 1978-05-16 Nippi, Incorporated Method of treating a wound or burn
US3876501A (en) * 1973-05-17 1975-04-08 Baxter Laboratories Inc Binding enzymes to activated water-soluble carbohydrates
US4174389A (en) * 1977-05-13 1979-11-13 Cope Louise A Ophthalmic use of collagenase
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US4485088A (en) * 1982-03-26 1984-11-27 Bio-Products, Inc. Method of treatment of fibrotic lesions by topical administration of lathyrogenic drugs
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor

Also Published As

Publication number Publication date
US5393792A (en) 1995-02-28
SI9200334A (en) 1993-06-30
HUT62802A (en) 1993-06-28
US5514370A (en) 1996-05-07
JPH0789871A (ja) 1995-04-04
CA2083333C (fr) 2000-05-30
EP0543521A2 (fr) 1993-05-26
AU654881B2 (en) 1994-11-24
ATE179612T1 (de) 1999-05-15
EP0543521B1 (fr) 1999-05-06
DE69229098D1 (de) 1999-06-10
YU98792A (sh) 1995-12-04
HU9203623D0 (en) 1993-01-28
AU2853592A (en) 1993-05-27
ES2130162T3 (es) 1999-07-01
DE69229098T2 (de) 1999-09-09
US5422103A (en) 1995-06-06
EP0543521A3 (en) 1993-07-28
RU2129862C1 (ru) 1999-05-10

Similar Documents

Publication Publication Date Title
CA2083333A1 (fr) Compositions a usage topique a forte dose de collagenase
RU92004549A (ru) Высокодозированные формы коллагеназы для наружного применения
MY118371A (en) Tetrahydrolipstatin containing compositions
ZA885192B (en) Pharmaceutical preparations
AR092919A2 (es) Composicion farmaceutica liquida
BR9303469A (pt) Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
AU2609592A (en) Pharmaceutical composition containing felbinac
AU5299593A (en) Methods of combating (pneumocystis carinii) pneumonia and compounds useful therefor
GR3030528T3 (en) Viscoelastic compositions of fluorinated organic compounds
IT1281188B1 (it) Composizione per prevenire e trattare infiammazioni con immunoglobulina a.
IT1252692B (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
PH23003A (en) Piroxicam monohydrate and aqueous pharmaceutical formulations containing same
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
EP0746294A4 (fr) Composes pour ameliorer l'absorption topique de formulations pharmaceutiques
NO932843L (no) Farmasoeytiske preparater
JPS5781409A (en) External plaster
EP0249193A3 (fr) Véhicule pour application topique de produits pharmaceutiques
AU2231688A (en) Stabilisation of therapeutically active proteins in a pharmaceutical composition
AU4353996A (en) Pharmaceutical tablet formulations for direct compression
AU7315596A (en) Pharmaceutical composition for topical application
EP0252033A3 (en) Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage
ATE33552T1 (de) Dermatologische praeparate.
AU6059094A (en) Active compound from a sponge
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed